APA (7th ed.) Citation

WY, C., XX, C., YR, F., R, Y., DM, S., D, H., . . . XX, Y. (2025). DNA methylation and immune evasion in triple-negative breast cancer: Challenges and therapeutic opportunities. Frontiers in oncology, 15, 1534055. https://doi.org/10.3389/fonc.2025.1534055

Chicago Style (17th ed.) Citation

WY, Cai, Cai XX, Fei YR, Ye R, Song DM, Hu D, Zhang WW, Xia MF, and Yang XX. "DNA Methylation and Immune Evasion in Triple-negative Breast Cancer: Challenges and Therapeutic Opportunities." Frontiers in Oncology 15 (2025): 1534055. https://doi.org/10.3389/fonc.2025.1534055.

MLA (9th ed.) Citation

WY, Cai, et al. "DNA Methylation and Immune Evasion in Triple-negative Breast Cancer: Challenges and Therapeutic Opportunities." Frontiers in Oncology, vol. 15, 2025, p. 1534055, https://doi.org/10.3389/fonc.2025.1534055.